Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer. - Ko, Dongmi; Park, Soeun; Park, Minsu; Kim, Seongjae; Park, Jung Min; Seo, Juyeon; Nam, Kee Dal; Kang, Yong Koo; Farrand, Lee; Jung, Eunsun; Kim, Yoon-Jae; Kim, Ji Young; et al. (Experimental Hematology & Oncology, 2025)